Clinical Trial

Investigation of an Intelligent Centre-adaptive Multi-modal Fusion Framework (Cad- MMFF) to Overcome Unnecessary Prostate Biopsies and Optimize MRI Utilization

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to investigate a novel Centre-Adaptive Multi-Modal Fusion Framework (Cad-MMFF) that integrates clinical, ultrasound, and MRI data to improve the detection of clinically significant prostate cancer (csPCa), reduce unnecessary biopsies, and optimize MRI utilization.
Trial Details
NCT Number NCT07760857
Lead Sponsor Chinese University of Hong Kong
Collaborators: The Hong Kong Polytechnic University
Conditions Prostate Cancer (Diagnosis)
Enrollment 400 participants
Start Date 2026-09-01
Primary Completion 2026-09-01 (estimated)
Study Completion 2030-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-12